Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DANICOPAN
- A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH
- A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults
- A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- A Study of the Cardiac Effects of Danicopan in Healthy Adults
- ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19
- Study of Different Forms of Danicopan (Tablet, Softgel Capsule, Liquid-filled Capsule) in Healthy Participants
- Study of Danicopan in Participants With Normal Kidney Function and Participants With Kidney Dysfunction
- Study of Multiple Doses of Danicopan in Healthy Participants
- Study of a Single Dose of Danicopan in Healthy Participants
- Study of Radiolabeled Danicopan in Healthy Male Participants
- A Drug Interaction Study of Danicopan
- Study of the Metabolism of Danicopan in Healthy Adults
- A Study of the Effects of Food and Age on Danicopan
- Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH)(ALPHA)
- Study of Danicopan in Participants of Japanese Descent
- Proof of Concept Study of ACH-0145228 in Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Study of Danicopan in Participants With Hepatic Impairment
- Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Response to Eculizumab
- A Proof of Concept Study for a 12 Month Treatment in Patients With C3 Glomerulopathy (C3G) or Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
- A Study of Modified Release Formulations of Danicopan in Healthy Adult Participants
- A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G)
- A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN
- A Drug Interaction Study Between Danicopan and Midazolam, Fexofenadine, and Mycophenolate Mofetil in Healthy Participants
- Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clinical trials list
click for details